0

Journal Articles

in Lipids and Lipid Disorders
 61-80 of 267 Articles
Original Contribution |  November 11, 2009 FREE
Statin Use and Risk of Gallstone Disease Followed by Cholecystectomy
Michael Bodmer, MD, MSc; Yolanda B. Brauchli, PhD, MSc; Stephan Krähenbühl, MD, PhD; et al.
JAMA. 2009;302(18):2001-2007. doi:10.1001/jama.2009.1601.
INCLUDES: , Supplemental Content
Original Contribution |  November 11, 2009 FREE
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA. 2009;302(18):1993-2000. doi:10.1001/jama.2009.1619.
INCLUDES: , Supplemental Content
Original Contribution |  October 28, 2009 FREE
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
Christoph U. Correll, MD; Peter Manu, MD; Vladimir Olshanskiy, MD; et al.
JAMA. 2009;302(16):1765-1773. doi:10.1001/jama.2009.1549.
INCLUDES: , Supplemental Content
Original Contribution |  October 21, 2009 FREE
Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease:  A Randomized Controlled Trial
Robert M. Carney, PhD; Kenneth E. Freedland, PhD; Eugene H. Rubin, MD, PhD; et al.
JAMA. 2009;302(15):1651-1657. doi:10.1001/jama.2009.1487.
Preliminary Communication |  September 16, 2009 FREE
Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome
Marietta Charakida, MD, PhD; Christian Besler, MD; Joana R. Batuca; et al.
JAMA. 2009;302(11):1210-1217. doi:10.1001/jama.2009.1346.
Review |  July 22, 2009 FREE
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
The Emerging Risk Factors Collaboration*
JAMA. 2009;302(4):412-423. doi:10.1001/jama.2009.1063.
INCLUDES: CME , Supplemental Content
Medical News & Perspectives |  June 24, 2009
FDA Tells Drug and Device Makers to Give Balanced Picture of Risks in Ads, Labels
Bridget M. Kuehn
JAMA. 2009;301(24):2541. doi:10.1001/jama.2009.881.
JAMA Classics |  June 17, 2009 FREE
Postmenopausal Hormone Treatment
Stephen Hulley, MD, MPH; Deborah Grady, MD, MPH
JAMA. 2009;301(23):2493-2495. doi:10.1001/jama.2009.847.
Original Contribution |  June 03, 2009 FREE
Timing and Tempo of First-Year Rapid Growth in Relation to Cardiovascular and Metabolic Risk Profile in Early Adulthood
Ralph W. J. Leunissen, MD; Gerthe F. Kerkhof, MSc; Theo Stijnen, MSc, PhD; et al.
JAMA. 2009;301(21):2234-2242. doi:10.1001/jama.2009.761.
Original Contribution |  May 27, 2009 FREE
Prevalence of Cardiovascular Disease Risk Factors Among National Football League Players
Andrew M. Tucker, MD; Robert A. Vogel, MD; Andrew E. Lincoln, ScD; et al.
JAMA. 2009;301(20):2111-2119. doi:10.1001/jama.2009.716.
Original Contribution |  March 18, 2009 FREE
ACAT Inhibition and Progression of Carotid Atherosclerosis in Patients With Familial Hypercholesterolemia:  The CAPTIVATE Randomized Trial
Marijn C. Meuwese, MD; Eric de Groot, MD, PhD; Raphaël Duivenvoorden, MD; et al.
JAMA. 2009;301(11):1131-1139. doi:10.1001/jama.301.11.1131.
Medical News & Perspectives |  February 25, 2009
Amid Lingering Questions, FDA Reprieves LDL Cholesterol–Lowering Medication
Mike Mitka
JAMA. 2009;301(8):813-815. doi:10.1001/jama.2009.196.
Medical News & Perspectives |  January 21, 2009
Researchers Worry About Myopathy Risk for Patients Taking High-Dose Simvastatin
Mike Mitka
JAMA. 2009;301(3):261-262. doi:10.1001/jama.2008.939.
Original Contribution |  January 14, 2009 FREE
Neurodevelopmental Outcomes of Preterm Infants Fed High-Dose Docosahexaenoic Acid:  A Randomized Controlled Trial
Maria Makrides, BSc, BND, PhD; Robert A. Gibson, BSc, PhD; Andrew J. McPhee, MBBS; et al.
JAMA. 2009;301(2):175-182. doi:10.1001/jama.2008.945.
JAMA Classics |  September 17, 2008 FREE
The Multiple Risk Factor Intervention Trial (MRFIT)—Importance Then and Now
Jeremiah Stamler, MD; James D. Neaton, PhD
JAMA. 2008;300(11):1343-1345. doi:10.1001/jama.300.11.1343.
INCLUDES: , Supplemental Content
Original Contribution |  September 17, 2008 FREE
Association of Urinary Bisphenol A Concentration With Medical Disorders and Laboratory Abnormalities in Adults
Iain A. Lang, PhD; Tamara S. Galloway, PhD; Alan Scarlett, PhD; et al.
JAMA. 2008;300(11):1303-1310. doi:10.1001/jama.300.11.1303.
The World in Medicine |  August 20, 2008
Gene Boosts Statin Risk
Joan Stephenson, PhD
JAMA. 2008;300(7):782. doi:10.1001/jama.300.7.782-a.
Original Contribution |  July 16, 2008 FREE
Effect of Simvastatin on Cognitive Functioning in Children With Neurofibromatosis Type 1:  A Randomized Controlled Trial
Lianne C. Krab, MSc; Arja de Goede-Bolder, MD; Femke K. Aarsen, MA; et al.
JAMA. 2008;300(3):287-294. doi:10.1001/jama.300.3.287.
Review |  June 18, 2008 FREE
Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
Alexander Thompson, MRes, MPhil; Emanuele Di Angelantonio, MD, MSc; Nadeem Sarwar, MRPharmS, MPhil; et al.
JAMA. 2008;299(23):2777-2788. doi:10.1001/jama.299.23.2777.
INCLUDES: CME , Supplemental Content
Original Contribution |  June 04, 2008 FREE
Association of Loss-of-Function Mutations in the ABCA1 Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
Ruth Frikke-Schmidt, MD, PhD; Børge G. Nordestgaard, MD, DMSc; Maria C. A. Stene, MSc, PhD; et al.
JAMA. 2008;299(21):2524-2532. doi:10.1001/jama.299.21.2524.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 6, 2013
Two New Drugs for Homozygous Familial Hypercholesterolemia:  Managing Benefits and Risks in a Rare Disorder
Robert J. Smith, MD; William R. Hiatt, MD
JAMA Internal Medicine
Research Letters  |  April 29, 2013
Limit to Benefits of Large Reductions in Low-Density Lipoprotein Cholesterol Levels: Use of Fractional Polynomials to Assess the Effect of Low-Density Lipoprotein Cholesterol Level Reduction in Metaregression of Large Statin Randomized Trials
Hisato Takagi, MD, PhD; Takuya Umemoto, MD, PhD; for the ALICE (All-Literature Investigation of Cardiovascular Evidence) Group
JAMA Internal Medicine
Invited Commentary  |  March 4, 2013
Getting to the Heart of HIV and Myocardial Infarction:  Comment on “HIV Infection and the Risk of Acute Myocardial Infarction”
Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI
JAMA Internal Medicine
Research Letters  |  April 08, 2013
A National Survey of the Treatment of Hyperlipidemia in Primary Prevention
Michael E. Johansen, MD; Katherine J. Gold, MD, MSW, MS; Ananda Sen, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems